ArticleJournal of hazardous materials2026
Lipidomic and neurobehavioral alterations from developmental lead exposure in zebrafish.
Article in Journal of hazardous materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Embryonic lead (Pb) contact impairs lipid, oxidative, and behavioral markers in zebrafish across multiple generations.Environmental research · 2026Article
- Atrazine alters kisspeptin signaling and downstream neuroendocrine regulation following embryonic exposure in zebrafish.Toxicology · 2026Article
- Developmental Toxicity and Thyroid-Disrupting Effects of Combined Exposure to Pb(II) andToxics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Lead (Pb) exposure during early development remains a major public health concern, with no identified safe threshold for developmental neurotoxicity. This study examined the effects of embryonic Pb exposure at environmentally relevant low concentrations (0.01, 0.1, and 1 ppb; µg/L) on neurodevelopmental outcomes in zebrafish (Danio rerio). Embryos were exposed during embryogenesis from 1 to 72 h post-fertilization (hpf), and larval zebrafish were evaluated for cognitive and behavioral performance, oxidative stress biomarkers, lipidomic alterations, and general developmental parameters. Pb-exposed larvae displayed significant cognitive impairments and anxiolytic-like behaviors, along with concentration-dependent disruptions in decision-making behaviors involving complex neural circuits. Developmental outcomes included altered spontaneous movement and heart rate variability. Biochemical assays revealed disrupted estradiol concentrations, late and improper modulation of antioxidant enzyme activities, and increased oxidative stress and lipid peroxidation. Lipidomic profiling showed early upregulation of triacylglycerol (TG) and cholesteryl esters (CE), accompanied by downregulation of sphingomyelin (SM) and phosphatidylcholine (PC) at 72 hpf. By 120 hpf, persistent reductions in phosphatidylethanolamine (PE), SM, and PC were observed, suggesting delayed metabolic reprogramming. Together, these results demonstrate even low Pb concentrations impair neurodevelopmental processes, alter lipid metabolism, and disrupt oxidative balance in zebrafish larvae. Importantly, the findings provide evidence of adverse effects below currently recognized exposure limits, underscoring the heightened sensitivity of the developing brain to Pb and raising concern for long-term cognitive and neurodevelopmental consequences in exposed populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.